Results 31 to 40 of about 103,051 (193)

Treatment and therapeutic strategies for pituitary apoplexy in pregnancy: a case series

open access: yesJournal of Medical Case Reports, 2021
Background Pregnancy is a known risk factor for pituitary apoplexy, which is life threatening for both mother and child. However, very few clinical interventions have been proposed for managing pituitary apoplexy in pregnancy.
Yuya Kato   +2 more
doaj   +1 more source

Rapidly Progressive Pituitary Apoplexy in a Patient with COVID-19 Disease Treated with Endoscopic Endonasal Surgery

open access: yesJournal of Neurological Surgery Reports, 2022
This report describes a case of pituitary apoplexy with rapidly evolving hemorrhage in a 74-year-old female with coronavirus disease 2019 (COVID-19) disease.
Charit Taneja   +5 more
doaj   +1 more source

Revisiting Pituitary Apoplexy

open access: yesJournal of the Endocrine Society, 2022
Abstract Pituitary apoplexy (PA) is a rare clinical syndrome due to pituitary hemorrhage or infarction. It is characterized by the sudden onset of one or more of the following: severe headache, visual disturbance, nausea/vomiting, and or altered mental status. Most commonly, PA occurs in an underlying pituitary adenoma.
Diane Donegan, Dana Erickson
openaire   +3 more sources

Pituitary apoplexy following endoscopic nasal surgery: A case report

open access: yesSAGE Open Medical Case Reports, 2019
Pituitary apoplexy develops as a consequence of acute haemorrhage and/or infarction in a pre-existing pituitary adenoma. Typical symptoms include sudden onset headache, visual acuity/field defects, and ocular palsies.
Teemu Harju, Juha Alanko, Jura Numminen
doaj   +1 more source

Pituitary apoplexy: a rare cause of middle cerebral artery infarction [PDF]

open access: yes, 2013
Pituitary apoplexy is a well-known complication of a pituitary adenoma. However, an ischaemic event caused by pituitary apoplexy is rare. We reported a case of pituitary apoplexy with middle cerebral artery infarction in a 44-year old man who ...
Abu Bakar, Azizi   +3 more
core   +1 more source

Pituitary tumor apoplexy [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2009
Pituitary tumor apoplexy is a medical emergency due to acute infarction or hemorrhage in the pituitary gland. In this review, the authors discuss the sellar anatomy, the pituitary gland and adenomas' vascularization and the general aspects of the syndrome such as its ethiopatogenesis, predisposing factors, clinical features, treatment and prognosis.
Chang, Claudia V.   +4 more
openaire   +4 more sources

Predisposing factors for pituitary apoplexy

open access: yes, 2014
Pituitary apoplexy is a rare threatening condition, still often misdiagnosed. In line with this the treating physician should be aware of pituitary apoplexy as a potential diagnoses whenever a patient seeks care with acute-onset headache associated with ...
Cirqueira, Cinthya Dos S. [UNESP]   +4 more
core   +1 more source

Chronic Central Adrenal Insufficiency in a Patient With Remote Traumatic Brain Injury and an Apparently Adequate Standard‐Dose ACTH Response: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT In patients with a remote history of traumatic brain injury, central adrenal insufficiency may remain unrecognized for decades. An apparently adequate response to standard‐dose ACTH stimulation should not preclude further evaluation of the hypothalamic–pituitary–adrenal axis when clinical and biochemical findings continue to suggest adrenal ...
Kazunori Kageyama   +5 more
wiley   +1 more source

Case report: Giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving COVID-19 vaccination

open access: yesFrontiers in Surgery, 2023
ObjectiveA case of giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving a COVID-19 vaccination is reported.Case presentationA 45-year-old man was referred for a giant pituitary tumor with ...
Haku Tanaka   +11 more
doaj   +1 more source

Prolactinomas in the transition from adolescence to young adulthood: A multicentre, retrospective study from the TALENT group

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Prolactinomas in the transition age present unique challenges; treatment strategies and long‐term outcomes in this population remain incompletely characterised. This is a multicentre, retrospective study of 110 consecutive patients (33 males) with prolactinomas, aged 15–25 years, across five Italian referral centres (2010–2025).
Dario De Alcubierre   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy